EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

AGXT2 Suppresses the Proliferation and Dissemination of Hepatocellular Carcinoma Cells by Modulating Intracellular Lipid Metabolism

Tian Chen, Lunjian Xiang, Wenjin Zhang iD, Zhenyi Xia iD, Weixian Chen

Journal of Hepatocellular Carcinoma · 2024-08 · Volume 11 · 1623-1639

DOI: 10.2147/jhc.s470250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2024-08. Verfasst von Tian Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Alanine glyoxylate aminotransferase (AGXT) family members are crucial in cancer processes, but their role in hepatocellular carcinoma (HCC) metabolism is unclear. This study investigates AGXT2's function in HCC. Patients and Methods: AGTX2 expression was studied using bioinformatics, real-time reverse transcriptase-polymerase chain reaction (RT-qPCR), Western blot, and Enzyme-linked immunosorbent assay (ELISA). A lentivirus-induced AGTX2 overexpression cell model was analyzed with RNA sequencing (RNA-seq) and liquid chromatography-mass spectrometry (LC-MS). Cholesterol levels were confirmed by Oil Red O staining. AGTX2 effects were evaluated through cell cycle analysis, wound healing, and transwell migration assays.Tumorigenic effects were observed in NOD-SCID IL2Rγnull (NTG) mice in subcutaneous experiments. Protein interaction was examined through co-immunoprecipitation methods.

Results

We observed a significant reduction in AGXT2 mRNA and protein levels in both HCC tumor tissues and serum samples from patients with liver cancer, which was associated with a worse prognosis. The activation of AGXT2 has been shown to effectively decrease cholesterol levels in liver cancer cells, serving as an antagonist in the cholesterol metabolism pathway. An increase in low density lipoprotein receptor (LDLR) mRNA was noted in cells overexpressing AGXT2, accompanied by a decrease in LDLR protein and an elevation in proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA and protein levels. Molecular docking and co-immunoprecipitation experiments further elucidated the interaction between AGXT2 and LDLR proteins. AGXT2 was observed to suppress the migratory and invasive capabilities of HCC cells, inducing cell cycle arrest in the G2/M phase. AGXT2 activation inhibited subcutaneous liver cancer tumor growth in NTG mice.

Conclusion

AGXT2 was found to lower cholesterol levels in liver cancer cells, possibly through interactions with the LDLR protein and modulation of PCSK9-mediated LDLR degradation. This mechanism may impede cholesterol transport to liver cancer cells, thereby suppressing their growth and metastasis.

Schlagwörter

Stichwörter der Autor:innen

LDLRPCSK9biomarkerscholesterol metabolic

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Hepatobiliary Surgery, Chongqing University Three Gorges Hospital, Chongqing, People's Republic of China.
  • Chongqing Municipality Clinical Research Center for Endocrinology and Metabolic Diseases, Chongqing University Three Gorges Hospital, Chongqing, People's Republic of China.
  • Thoracic surgery, Chongqing University Three Gorges Hospital, Chongqing, People's Republic of China.

ORCID-Profile: Wenjin Zhang, Zhenyi Xia

Zitieren

APA

Chen, T., Xiang, L., Zhang, W., Xia, Z., & Chen, W. (2024). AGXT2 Suppresses the Proliferation and Dissemination of Hepatocellular Carcinoma Cells by Modulating Intracellular Lipid Metabolism. Journal of Hepatocellular Carcinoma, Volume 11, 1623-1639. https://doi.org/10.2147/jhc.s470250

Vancouver

Chen T, Xiang L, Zhang W, Xia Z, Chen W. AGXT2 Suppresses the Proliferation and Dissemination of Hepatocellular Carcinoma Cells by Modulating Intracellular Lipid Metabolism. Journal of Hepatocellular Carcinoma. 2024;Volume 11:1623-1639. doi:10.2147/jhc.s470250

BibTeX
@article{Chen2024,
  author = {Chen, Tian and Xiang, Lunjian and Zhang, Wenjin and Xia, Zhenyi and Chen, Weixian},
  title = {AGXT2 Suppresses the Proliferation and Dissemination of Hepatocellular Carcinoma Cells by Modulating Intracellular Lipid Metabolism},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2024},
  volume = {Volume 11},
  pages = {1623--1639},
  doi = {10.2147/jhc.s470250}
}
Kostenlos starten →